This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Dhanda R, Gondek K, Song J, Cella D, Bukowski RM, Escudier B.A quality of life, symptoms and survival comparison in kidney cancer patients receiving sorafenib versus placebo. Annals of Oncology 17 (Suppl. 9): 147, Sep 2006
Rights and permissions
About this article
Cite this article
Sorafenib therapy does not compromise the QOL of patients with renal cancer,. Pharmacoecon. Outcomes News 516, 9 (2006). https://doi.org/10.2165/00151234-200605160-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605160-00023